Sepracor, Inc. Announces Presentation Of LUNESTA(TM) Posters At Associated Professional Sleep Societies Annual Meeting

MARLBOROUGH, Mass.--(BUSINESS WIRE)--June 21, 2006--Sepracor Inc. (Nasdaq: SEPR - News) today announced that data for LUNESTA(TM) brand eszopiclone for the treatment of insomnia were presented at the SLEEP 2006 20th Anniversary Meeting of the Associated Professional Sleep Societies in Salt Lake City. The data included four poster presentations of results from LUNESTA Phase IIIB/IV studies.

Back to news